Clinical Trial 47374

Beverly Hills, CA 90211




Study Type: Interventional  (Clinical Trial)

Estimated Enrollment  :44 participants


Intervention Model:Single Group Assignment

Masking:None (Open Label)

Primary Purpose:Treatment

Official Title:A Phase I/Ib Open-Label, Multi-Center, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of Intravenous NBF 006 in Patients With Non-Small Cell Lung, Pancreatic, or Colorectal Cancer Followed by a Dose Expansion Study in Patients With KRAS-Mutated Non-Small Cell Lung Cancer

Qualified Participants Must:

• Have histologically or cytologically confirmed progressive or metastatic NSCLC with documented KRAS-mutant genotype, who have failed standard treatment and have no other effective treatment available or appropriate for the patient.

Qualified Participants May Receive:

Experimental: NBF-006

Intravenous infusion, once-weekly x 4 consecutive weeks, every 6 weeks

Available At:

Beverly Hills Cancer Center

Beverly Hills, CA 90211
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.